Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 138.60
-2.00 (-1.42%)
Jul 14, 2026, 12:42 PM CET
Medacta Group Market Cap
Medacta Group has a market cap or net worth of 2.8 billion as of July 14, 2026. Its market cap has increased by 5.67% in one year.
Market Cap
2.80B
Enterprise Value
3.01B
Revenue
636.66M
Ranking
n/a
PE Ratio
31.59
Stock Price
138.60
Market Cap Chart
Since April 4, 2019, Medacta Group's market cap has increased from 1.92B to 2.80B, an increase of 45.66%. That is a compound annual growth rate of 5.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 2.80B | -10.25% |
| Dec 30, 2025 | 3.12B | 46.66% |
| Dec 30, 2024 | 2.13B | -15.15% |
| Dec 29, 2023 | 2.51B | 21.81% |
| Dec 30, 2022 | 2.06B | -27.53% |
| Dec 30, 2021 | 2.84B | 62.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.70B |
| Novartis AG | 227.50B |
| Lonza Group AG | 41.11B |
| Galderma Group AG | 40.55B |
| Bachem Holding AG | 5.61B |
| Ypsomed Holding AG | 4.75B |
| Galenica AG | 4.36B |
| Siegfried Holding AG | 3.18B |